Our study reveals that RHOF not only enhances the tumor antigen presentation process but also leads to a significant increase in the levels of various effector tumor-infiltrating immune cells, such as CD8+T cells, TH22 cells, and TH1 cells, in the high-RHOF group. Here, CD8A is linked to neoplasm.